163 related articles for article (PubMed ID: 25051904)
1. Atypical Femoral Fractures: A Teaching Perspective.
Khan AA; Leslie WD; Lentle B; Iles S; Kaiser SM; Frame H; Burrell S; Cheung AM
Can Assoc Radiol J; 2015 May; 66(2):102-7. PubMed ID: 25051904
[TBL] [Abstract][Full Text] [Related]
2. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP
J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
[TBL] [Abstract][Full Text] [Related]
3. Atypical Femoral Fractures : Three Cases And A Review Of Literature.
Van Lieshout M; Putzeys G; Goemaere S; Van Der Straeten C; Audenaert E
Acta Orthop Belg; 2017 Dec; 83(4):558-567. PubMed ID: 30423662
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-associated atypical femur fracture in a 90-year-old Caucasian woman.
Gopinath KG; Shibu PK
Hong Kong Med J; 2015 Jun; 21(3):286.e2-3. PubMed ID: 26045077
[No Abstract] [Full Text] [Related]
5. Atypical femur fractures associated with use of bisphosphonates and denosumab.
Farooki A; Fornier M; Boland P
Ann Oncol; 2015 Apr; 26(4):819-820. PubMed ID: 25605743
[No Abstract] [Full Text] [Related]
6. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
Genest F; Seefried L
Osteoporos Int; 2018 Aug; 29(8):1815-1825. PubMed ID: 29774402
[TBL] [Abstract][Full Text] [Related]
7. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Ebeling PR; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster D; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Koval K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Sen HT; van der Meulen MC; Weinstein RS; Whyte M;
J Bone Miner Res; 2010 Nov; 25(11):2267-94. PubMed ID: 20842676
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
Ramchand SK; Chiang CY; Zebaze RM; Seeman E
Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
[TBL] [Abstract][Full Text] [Related]
9. Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!
Rydholm A
Acta Orthop; 2012 Aug; 83(4):319-20. PubMed ID: 22900912
[No Abstract] [Full Text] [Related]
10. Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer.
Kordoni M; Rigakos G; Kim YHM; Kaklamanis L; Nikolatou-Galitis O; Hadjiyassemi L; Labropoulos S; Razis E
Anticancer Res; 2018 Nov; 38(11):6439-6444. PubMed ID: 30396969
[TBL] [Abstract][Full Text] [Related]
11. Atypical femoral fractures bilaterally in a patient receiving denosumab.
Drampalos E; Skarpas G; Barbounakis N; Michos I
Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
[No Abstract] [Full Text] [Related]
12. Atypical femoral fractures as an incidental finding on dual X-ray absorptiometry.
Powrie N; Ismail A
Rheumatology (Oxford); 2015 Feb; 54(2):218. PubMed ID: 25477055
[No Abstract] [Full Text] [Related]
13. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
Park KT; Lee KB
Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
[TBL] [Abstract][Full Text] [Related]
14. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M
Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556
[TBL] [Abstract][Full Text] [Related]
16. A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
Dell R; Greene D
Osteoporos Int; 2018 Jun; 29(6):1277-1283. PubMed ID: 29675745
[TBL] [Abstract][Full Text] [Related]
17. Atypical fracture of the femur in a patient using denosumab--a case report.
Schilcher J; Aspenberg P
Acta Orthop; 2014 Feb; 85(1):6-7. PubMed ID: 24460109
[No Abstract] [Full Text] [Related]
18. Atypical diaphyseal femoral fractures--new aspects.
Feldman F
Skeletal Radiol; 2012 Jan; 41(1):75-81. PubMed ID: 21369720
[TBL] [Abstract][Full Text] [Related]
19. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
Reddy SV; Gupta SK
Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
[TBL] [Abstract][Full Text] [Related]
20. Atypical femoral fracture in a metastatic bone disease patient six months after discontinuation of denosumab received sequentially to previous bisphosphonate therapy - A case report.
Georgiadis GF; Balanika AP; Vasilakis AΕ; Begkas DG; Baltas CS; Pastroudis AP
J Musculoskelet Neuronal Interact; 2021 Sep; 21(3):429-433. PubMed ID: 34465683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
